Orthofix Medical Inc. (OFIX) stock
OFIXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 23
$6.67−0.13 (-1.91%)
Close on Nov 17, 2026Market cap $271.69MP/E –Yield –
Orthofix Medical revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Orthofix Medical's revenue for the twelve months ending Jun 30, 2026 was $833.19M, up 3.0% year over year. For fiscal 2025 it was $822.31M, up 2.9% from the year before. Over ten years it grew 7.6% a year on average. The highest annual figure on record is $822.31M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $822.31M | +2.9% |
| FY2024 | Dec 31, 2024 | $799.49M | +7.1% |
| FY2023 | Dec 31, 2023 | $746.64M | +62.1% |
| FY2022 | Dec 31, 2022 | $460.71M | -0.8% |
| FY2021 | Dec 31, 2021 | $464.48M | +14.2% |
| FY2020 | Dec 31, 2020 | $406.56M | -11.6% |
| FY2019 | Dec 31, 2019 | $459.96M | +1.5% |
| FY2018 | Dec 31, 2018 | $453.04M | +4.4% |
| FY2017 | Dec 31, 2017 | $433.82M | +5.9% |
| FY2016 | Dec 31, 2016 | $409.79M | +3.4% |
| FY2015 | Dec 31, 2015 | $396.49M | -1.4% |
| FY2014 | Dec 31, 2014 | $402.28M | +1.2% |
| FY2013 | Dec 31, 2013 | $397.61M | -9.7% |
| FY2012 | Dec 31, 2012 | $440.19M | +1.1% |
| FY2011 | Dec 31, 2011 | $435.52M | -5.8% |
| FY2010 | Dec 31, 2010 | $462.57M | -15.2% |
| FY2009 | Dec 31, 2009 | $545.64M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $210.93M | +3.8% |
| Q1 FY2026 | Mar 31, 2026 | $196.71M | +1.6% |
| Q4 FY2025 | Dec 31, 2025 | $219.91M | +2.0% |
| Q3 FY2025 | Sep 30, 2025 | $205.63M | +4.6% |
| Q2 FY2025 | Jun 30, 2025 | $203.12M | +2.3% |
| Q1 FY2025 | Mar 31, 2025 | $193.65M | +2.7% |
| Q4 FY2024 | Dec 31, 2024 | $215.66M | +7.6% |
| Q3 FY2024 | Sep 30, 2024 | $196.61M | +6.8% |
| Q2 FY2024 | Jun 30, 2024 | $198.62M | +6.2% |
| Q1 FY2024 | Mar 31, 2024 | $188.61M | +7.7% |
| Q4 FY2023 | Dec 31, 2023 | $200.42M | +64.0% |
| Q3 FY2023 | Sep 30, 2023 | $184.01M | +61.4% |
| Q2 FY2023 | Jun 30, 2023 | $187.02M | +58.4% |
| Q1 FY2023 | Mar 31, 2023 | $175.20M | +64.6% |
| Q4 FY2022 | Dec 31, 2022 | $122.23M | -2.3% |
| Q3 FY2022 | Sep 30, 2022 | $114.00M | +1.4% |
| Q2 FY2022 | Jun 30, 2022 | $118.07M | -2.7% |
| Q1 FY2022 | Mar 31, 2022 | $106.42M | +0.8% |
| Q4 FY2021 | Dec 31, 2021 | $125.06M | +6.3% |
| Q3 FY2021 | Sep 30, 2021 | $112.43M | +1.3% |
| Q2 FY2021 | Jun 30, 2021 | $121.39M | +66.0% |
| Q1 FY2021 | Mar 31, 2021 | $105.59M | +0.7% |
| Q4 FY2020 | Dec 31, 2020 | $117.62M | -3.2% |
| Q3 FY2020 | Sep 30, 2020 | $110.99M | -2.2% |
| Q2 FY2020 | Jun 30, 2020 | $73.14M | -36.9% |
| Q1 FY2020 | Mar 31, 2020 | $104.82M | -3.9% |
| Q4 FY2019 | Dec 31, 2019 | $121.49M | +0.3% |
| Q3 FY2019 | Sep 30, 2019 | $113.50M | +1.6% |
| Q2 FY2019 | Jun 30, 2019 | $115.85M | +3.9% |
| Q1 FY2019 | Mar 31, 2019 | $109.11M | +0.4% |
| Q4 FY2018 | Dec 31, 2018 | $121.08M | +3.6% |
| Q3 FY2018 | Sep 30, 2018 | $111.71M | +6.1% |
| Q2 FY2018 | Jun 30, 2018 | $111.55M | +2.4% |
| Q1 FY2018 | Mar 31, 2018 | $108.71M | +5.8% |
| Q4 FY2017 | Dec 31, 2017 | $116.90M | +7.7% |
| Q3 FY2017 | Sep 30, 2017 | $105.25M | +6.9% |
| Q2 FY2017 | Jun 30, 2017 | $108.94M | – |
| Q1 FY2017 | Mar 31, 2017 | $102.74M | – |
| Q4 FY2016 | Dec 31, 2016 | $108.54M | – |
| Q3 FY2016 | Sep 30, 2016 | $98.50M | – |
See a number that looks wrong?